Pfizer gets full US FDA nod for LORBRENA as first-line treatment for ALK-Positive metastatic NSCLC Read more
Pfizer gets US FDA approval for PANZYGA to treat chronic inflammatory demyelinating polyneuropathy Read more
Pfizer gets USFDA nod for XALKORI (crizotinib) to treat ALK-positive ALCL in children and young adults Read more